Discover 743 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 743
FeaturedActive & ResponsiveNew
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Oklahoma City OK, Flower Mound TX, Little Rock AR,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Edmond OK, Oklahoma City OK, Yukon OK, Tulsa OK,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Oklahoma City OK, Duarte CA
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Location: Oklahoma City OK, Wichita KS, Houston TX, Jackson MS,
Sponsor: Procyrion
Sex: All
Age: 21+
Code: NCT05677100
Recruiting
Active & Responsive
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Oklahoma City OK, Joplin MO, Dallas TX, Westwood KS,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase3, Recruiting
Active & Responsive
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: Oklahoma City OK, Houston TX, Webster TX, Nashville TN,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05431270
Phase1, Phase2, Recruiting
Active & Responsive
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Oklahoma City OK, Irving TX, Houston TX, San Antonio TX,